DYAI Latest Press Releases

-- October 30, 2026 --

Dyadic to Report Q3 2026 Financial Results and Host Conference Call on Thursday November 12, 2026 Globe Newswire 4:05 PM

-- September 8, 2026 --

iAccess Alpha Virtual Best Ideas Fall Investment Conference, September 15-16, 2026 ACCESS Newswire 9:00 AM

-- August 13, 2026 --

Dyadic International, Inc. Secures $2.9 Million Through Registered Direct Offering and Concurrent Private Placement Globe Newswire 8:00 AM

-- August 12, 2026 --

Dyadic Announces Second Quarter 2026 Financial Results Accelerating Commercialization Momentum Across Key Business Areas Globe Newswire 8:30 AM

-- August 4, 2026 --

Dyadic Expands Commercial Non-Animal Dairy Pipeline Through New Strategic Development Agreement Globe Newswire 7:25 AM

-- August 3, 2026 --

Dyadic to Report Q2 2026 Financial Results and Host Conference Call on Wednesday August 12, 2026 Globe Newswire 4:30 PM

-- July 28, 2026 --

Dyadic Develops Stable C1 Cell Lines and Produces Purified Scripps-Designed Bundibugyo Ebola Antigens from Plasmids in Approximately 15 Days Globe Newswire 8:30 AM

-- July 24, 2026 --

Dyadic Announces Continued Listing on the Nasdaq Capital Market Globe Newswire 7:30 AM

-- July 16, 2026 --

Dyadic Expands Bio industrial Pipeline with New Proprietary Industrial Enzyme Program Globe Newswire 8:00 AM

-- July 7, 2026 --

Global Collaborations Continue to Validate Dyadic's C1 Platform and Expands Commercial Potential Globe Newswire 7:25 AM

-- June 29, 2026 --

Dyadic Expands IP Protection and Business Development Activities in Japan Globe Newswire 7:25 AM

-- June 15, 2026 --

Dyadic Highlights Accelerated Interest in C1 Biomanufacturing Platform Amid Ebola Preparedness Activities and Growing Commercial Adoption Globe Newswire 7:25 AM

Market Data Delayed 15 Minutes